Statin and the risk of hepatocellular carcinoma in patients with hepatitis B virus or hepatitis C virus infection: a meta-analysis
Statin may confer anticancer effect. However, the association between statin and risk of hepatocellular carcinoma (HCC) in patients with hepatitis B virus (HBV) or hepatitis C (HCV) virus infection remains inc...
Source: BMC Gastroenterology - Category: Gastroenterology Authors: Xiaofei Li, Lina Sheng, Liwen Liu, Yongtao Hu, Yongxin Chen and Lianqing Lou Tags: Research article Source Type: research
More News: Cancer & Oncology | Carcinoma | Cholesterol | Gastroenterology | Hepatitis | Hepatitis B | Hepatitis C | Hepatocellular Carcinoma | Liver Cancer | Statin Therapy